Company News
Aptus Pharma Board Approves ₹51 Crore Fund Raising
Aptus Pharma board approved in-principle fund raising of ₹51 crore for business expansion via preferential allotment, debt, and internal accruals.
Managing Director Tejas Hathi authorized to identify